PCI Biotech announced the appointment of Dr. Hans Olivecrona MD PhD as Chief Medical Officer. Olivecrona will also serve as a member of PCI Biotech's executive management team. He will lead the execution of all clinical development programmes, and be a key contributor to the identification and implementation of new opportunities and pipeline expansions. Olivecrona brings extensive experience in the development and commercialisation of novel therapeutics. In his most recent role, Olivecrona held the position as Senior Medical Director at Swedish Orphan Biovitrum (Sobi AB) in Stockholm, Sweden, with the responsibility for medical affairs and all medical aspects of business development for Sobi's international partner product portfolio.